Effects of Breezy Candy on Halitosis

NCT ID: NCT00875927

Last Updated: 2009-04-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Users of Breezy candy will utilize the candy's abrasiveness to scrape tongue surface. The scraping action together with the release of compounds contained inside the abrasive microcapsules will result in significant reduction of oral halitosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Halitosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 - control

candy not including scraping microcapsules

Group Type ACTIVE_COMPARATOR

no scraping microcapsules

Intervention Type OTHER

1, 4 grams isomalt candy containing no scraping microcapsules

2 - Scraping

candy including scraping TCP microcapsules

Group Type ACTIVE_COMPARATOR

scraping microcapsules containing inert TCP microcapsules

Intervention Type OTHER

1, 4 grams isomalt candy containing 2% inert TCP scraping microcapsules

3 - Scraping plus Propolis

candy including scraping Propolis microcapsules

Group Type ACTIVE_COMPARATOR

scraping microcapsules containing Propolis

Intervention Type OTHER

1, 4 grams, isomalt candy containing 2% Propolis scraping microcapsules

4 - Scraping plus Zinc

candy including scraping Zinc microcapsules

Group Type ACTIVE_COMPARATOR

scraping microcapsules containing and Zinc

Intervention Type OTHER

1, 4 grams, isomalt candy containing 2% Zinc scraping microcapsules

5 - Scraping plus Propolis and Zinc

candy including scraping Propolis and Zinc microcapsules

Group Type ACTIVE_COMPARATOR

scraping microcapsules containing Propolis and Zinc

Intervention Type OTHER

1, 4 grams, isomalt candy containing 2% Propolis and Zinc scraping microcapsules

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no scraping microcapsules

1, 4 grams isomalt candy containing no scraping microcapsules

Intervention Type OTHER

scraping microcapsules containing inert TCP microcapsules

1, 4 grams isomalt candy containing 2% inert TCP scraping microcapsules

Intervention Type OTHER

scraping microcapsules containing Propolis

1, 4 grams, isomalt candy containing 2% Propolis scraping microcapsules

Intervention Type OTHER

scraping microcapsules containing and Zinc

1, 4 grams, isomalt candy containing 2% Zinc scraping microcapsules

Intervention Type OTHER

scraping microcapsules containing Propolis and Zinc

1, 4 grams, isomalt candy containing 2% Propolis and Zinc scraping microcapsules

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult
* healthy
* male
* female
* bad breath

Exclusion Criteria

* subject suffering from Diabetes
* subject suffering from renal disease
* pregnant women
* cigarette smokers
* any illness of oral cavity for the last 3 months
* subjects undergoing chemotherapy
* treatment by antibiotic
* treatment by anti-inflammatory
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Breezy Industries Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Breezy Industries Ltd.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shlomo Barak, MD

Role: PRINCIPAL_INVESTIGATOR

Mouth and Jaw institute, Hillel Yaffe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hillel Yaffe Medical Center

Hadera, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Maya Eshed, MSc, MBA

Role: CONTACT

972-54-4498669

Yoram Rubin

Role: CONTACT

972-4-8342155

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shlomi Ashtar

Role: primary

972-4-6304930

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BCHS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Burning Mouth Syndrome: Symptoms and Management
NCT07016555 RECRUITING EARLY_PHASE1
Green Tea Lozenges for the Management of Dry Mouth
NCT01647737 COMPLETED PHASE1/PHASE2
Effectiveness of Aquamin® in Mitigating Halitosis
NCT05058638 ACTIVE_NOT_RECRUITING PHASE2